NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $488,928 | +0.9% | 4,800 | 0.0% | 0.03% | +3.7% |
| Q2 2023 | $484,368 | +14.5% | 4,800 | +4.3% | 0.03% | +8.0% |
| Q1 2023 | $423,200 | +79002.8% | 4,600 | -22.0% | 0.02% | -16.7% |
| Q4 2022 | $535 | -99.9% | 5,896 | +25.4% | 0.03% | +30.4% |
| Q3 2022 | $357,000 | -6.1% | 4,700 | +4.4% | 0.02% | 0.0% |
| Q2 2022 | $380,000 | -3.8% | 4,500 | 0.0% | 0.02% | +9.5% |
| Q1 2022 | $395,000 | -3.2% | 4,500 | -3.5% | 0.02% | 0.0% |
| Q4 2021 | $408,000 | -16.4% | 4,665 | -21.8% | 0.02% | -22.2% |
| Q3 2021 | $488,000 | -7.8% | 5,965 | +2.8% | 0.03% | -10.0% |
| Q2 2021 | $529,000 | +4.8% | 5,800 | -1.9% | 0.03% | +3.4% |
| Q1 2021 | $505,000 | -9.5% | 5,912 | 0.0% | 0.03% | -12.1% |
| Q4 2020 | $558,000 | +8.6% | 5,912 | 0.0% | 0.03% | 0.0% |
| Q3 2020 | $514,000 | -0.4% | 5,912 | 0.0% | 0.03% | -8.3% |
| Q2 2020 | $516,000 | +13.2% | 5,912 | +6.9% | 0.04% | -2.7% |
| Q1 2020 | $456,000 | -20.7% | 5,532 | -9.0% | 0.04% | -2.6% |
| Q4 2019 | $575,000 | +43.4% | 6,076 | +31.7% | 0.04% | +31.0% |
| Q3 2019 | $401,000 | -4.8% | 4,612 | 0.0% | 0.03% | -6.5% |
| Q2 2019 | $421,000 | -5.0% | 4,612 | 0.0% | 0.03% | -6.1% |
| Q1 2019 | $443,000 | +11.9% | 4,612 | 0.0% | 0.03% | 0.0% |
| Q4 2018 | $396,000 | +27.7% | 4,612 | +28.1% | 0.03% | +50.0% |
| Q3 2018 | $310,000 | +14.0% | 3,600 | 0.0% | 0.02% | +4.8% |
| Q2 2018 | $272,000 | -6.5% | 3,600 | 0.0% | 0.02% | -4.5% |
| Q1 2018 | $291,000 | -3.6% | 3,600 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $302,000 | -2.3% | 3,600 | 0.0% | 0.02% | -8.3% |
| Q3 2017 | $309,000 | +3.0% | 3,600 | 0.0% | 0.02% | +4.3% |
| Q2 2017 | $300,000 | +12.4% | 3,600 | 0.0% | 0.02% | +4.5% |
| Q1 2017 | $267,000 | +0.8% | 3,600 | -1.0% | 0.02% | -4.3% |
| Q4 2016 | $265,000 | -6.7% | 3,635 | +1.0% | 0.02% | -4.2% |
| Q3 2016 | $284,000 | -4.4% | 3,600 | 0.0% | 0.02% | 0.0% |
| Q2 2016 | $297,000 | +13.8% | 3,600 | 0.0% | 0.02% | +9.1% |
| Q1 2016 | $261,000 | +21.4% | 3,600 | +44.0% | 0.02% | +15.8% |
| Q4 2015 | $215,000 | -6.5% | 2,500 | 0.0% | 0.02% | -9.5% |
| Q3 2015 | $230,000 | -6.5% | 2,500 | 0.0% | 0.02% | +5.0% |
| Q2 2015 | $246,000 | -0.4% | 2,500 | 0.0% | 0.02% | +5.3% |
| Q1 2015 | $247,000 | – | 2,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |